AIM’s Latest Newsletter: The Research Edition, July 2023

Published:  
08/01/2023
Categories:  
Blog - Melanoma360
 | 
Melanoma Research
Image

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.

This edition features:

  • Letter from AIM’s President, Sam Guild
  • Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
    By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory
  • In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
    By Kim Margolin, M.D., FACP, FASCO
  • Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
    By Alicia Rowell, Vice President, AIM at Melanoma

Recent Posts

Featured image for “The FDA Said No — Now We Need Your Voice”
Jul. 25, 2025

The FDA Said No — Now We Need Your Voice

Featured image for “Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar”
Jul. 18, 2025

Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar

Featured image for “The Cost of Sunscreen May Be Costing Lives”
Jul. 01, 2025

The Cost of Sunscreen May Be Costing Lives

Featured image for “A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients”
Jul. 01, 2025

A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients

Featured image for “Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative ”
Jun. 18, 2025

Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative 

Filter by Tag